Correction: Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee

• James L. Januzzi,
• Joseph M. Garasic,
• Scott E. Kasner,
• Vickie McDonald,
• Mark C. Petrie,
• Jonathan Seltzer,
• Michael Mauro,
• Kevin Croce,
• Ellin Berman,
• Michael Deininger,
• Andreas Hochhaus,
• Javier Pinilla-Ibarz,
• Franck Nicolini,
• Dong-Wook Kim,
• Daniel J. DeAngelo,
• Hagop Kantarjian,
• Jing Xu,
• Tracey Hall,
• Shouryadeep Srivastava,
• Daniel Naranjo,
• Jorge Cortes

Affiliations

James L. Januzzi

Massachusetts General Hospital

Joseph M. Garasic

Massachusetts General Hospital

Scott E. Kasner

University of Pennsylvania

Vickie McDonald

Barts Health NHS Trust

Mark C. Petrie

University of Glasgow

Jonathan Seltzer

ACI Clinical

Michael Mauro

Memorial Sloan Kettering Cancer Center

Kevin Croce

Brigham and Women’s Hospital, Harvard Medical School

Ellin Berman

Memorial Sloan Kettering Cancer Center

Michael Deininger

Huntsman Cancer Institute, The University of Utah

Andreas Hochhaus

Universitätsklinikum Jena

Javier Pinilla-Ibarz

H. Lee Moffitt Cancer Center & Research Institute

Franck Nicolini

Centre Hospitalier Lyon-Sud

Dong-Wook Kim

Catholic Hematology Hospital, Seoul St. Mary’s Hospital, Leukemia Research Institute, The Catholic University of Korea

Daniel J. DeAngelo

Dana-Farber Cancer Institute

Hagop Kantarjian

The University of Texas MD Anderson Cancer Center

Jing Xu

Millennium Pharmaceuticals, Inc., A Wholly Owned Subsidiary of Takeda Pharmaceutical Company Limited

Tracey Hall

Millennium Pharmaceuticals, Inc., A Wholly Owned Subsidiary of Takeda Pharmaceutical Company Limited

Shouryadeep Srivastava

Millennium Pharmaceuticals, Inc., A Wholly Owned Subsidiary of Takeda Pharmaceutical Company Limited

Daniel Naranjo

Millennium Pharmaceuticals, Inc., A Wholly Owned Subsidiary of Takeda Pharmaceutical Company Limited

Jorge Cortes

Georgia Cancer Center